Allogeneic Cell-Mediated Immunotherapy at the Stage of Minimal Residual Disease following High-Dose Chemotherapy Supported by Autologous Stem Cell Transplantation

Publisher: Karger

E-ISSN: 1421-9662|114|4|214-220

ISSN: 0001-5792

Source: Acta Haematologica, Vol.114, Iss.4, 2005-11, pp. : 214-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract